Success Metrics

Clinical Success Rate
88.2%

Based on 15 completed trials

Completion Rate
88%(15/17)
Active Trials
0(0%)
Results Posted
33%(5 trials)
Terminated
2(12%)

Phase Distribution

Ph phase_2
3
18%
Ph phase_3
7
41%
Ph phase_4
6
35%
Ph not_applicable
1
6%

Phase Distribution

0

Early Stage

3

Mid Stage

13

Late Stage

Phase Distribution17 total trials
Phase 2Efficacy & side effects
3(17.6%)
Phase 3Large-scale testing
7(41.2%)
Phase 4Post-market surveillance
6(35.3%)
N/ANon-phased studies
1(5.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.2%

15 of 17 finished

Non-Completion Rate

11.8%

2 ended early

Currently Active

0

trials recruiting

Total Trials

17

all time

Status Distribution
Completed(15)
Terminated(2)

Detailed Status

Completed15
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
17
Active
0
Success Rate
88.2%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (17.6%)
Phase 37 (41.2%)
Phase 46 (35.3%)
N/A1 (5.9%)

Trials by Status

completed1588%
terminated212%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT00078754Phase 2

A Comparison of Fluoxetine and Divalproex for the Treatment of Intermittent Explosive Disorder

Completed
NCT01588457Phase 4

Sequential Multiple Assignment Treatment for Bipolar Disorder

Completed
NCT00194129Phase 3

Lithium and Divalproex for the Treatment of Comorbid Rapid Cycling Bipolar Disorder and Substance Abuse Disorder

Completed
NCT00203385Phase 4

Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder

Terminated
NCT02078596Phase 4

Depakote (Divalproex Sodium) for Children With Temper Dysregulation and Severe Mood Swings

Completed
NCT00063362Phase 3

Combination Therapy for the Treatment of Bipolar Disorders

Terminated
NCT00108576Phase 3

Divalproex Sodium in the Treatment of PTSD (Post-Traumatic Stress Disorder)

Completed
NCT00221975Phase 3

Combination Therapy in Dual Diagnosis Bipolar Rapid Cycling

Completed
NCT00048802Phase 4

Treatment and Outcome of Early Onset Bipolar Disorder

Completed
NCT00208819Phase 4

A Comparison of Two Standard Therapies in the Management of Dementia With Agitation

Completed
NCT00114686Phase 3

Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

Completed
NCT00278772Phase 3

Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania

Completed
NCT00402324Phase 4

A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients

Completed
NCT00107731Phase 3

Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder

Completed
NCT00347152Not Applicable

Comparison of Immediate vs Gradual Switch to Divalproex in Adults With Intellectual Disability

Completed
NCT00088387Phase 2

Effect of Lithium and Divalproex in Alzheimer's Disease

Completed
NCT00095355Phase 2

Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17